What is NDC 70382-204?

70382-204 is the product NDC for Dextenza (dexamethasone), Dexamethasone .4 mg/1 insert, listed with the FDA by Ocular Therapeutix, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Ocular Therapeutix, Inc., NDC labeler code 70382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dextenza?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dextenza NDC 70382-204 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70382-204Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70382-0204Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70382-204-01	70382020401	1 POUCH in 1 BOX, UNIT-DOSE (70382-204-01) / 1 INSERT in 1 POUCH (70382-204-88)Marketed from Jan 7, 2019
70382-204-10	70382020410	10 POUCH in 1 BOX, UNIT-DOSE (70382-204-10) / 1 INSERT in 1 POUCH (70382-204-88)Marketed from Jan 7, 2019
70382-204-99	70382020499	1 POUCH in 1 BOX, UNIT-DOSE (70382-204-99) / 1 INSERT in 1 POUCH (70382-204-88)Marketed from Jan 7, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextenza
Generic name (nonproprietary): dexamethasone
Active ingredients: Dexamethasone — .4 mg/1
Dosage form: Insert
Route: Intracanalicular, Ophthalmic
Labeler: Ocular Therapeutix, Inc.NDC labeler code 70382
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 208742
Marketing start: Jan 7, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 70382-204_ad2305a4-f888-4800-a31e-1fff3ffee20dSPL ID ad2305a4-f888-4800-a31e-1fff3ffee20dSPL set ID 7514e6b8-c33f-4fbf-8810-ef520e1eb4bdRxCUI 2108015, 2108020UNII 7S5I7G3JQLUPC 0370382204885
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N470382020401 followed by a unit qualifier and the quantity

Package 70382-0204-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 18, 2025.

Indications (excerpt from the label)

DEXTENZA ® is a corticosteroid indicated for: The treatment of ocular inflammation and pain following ophthalmic surgery in adults and pediatric patients. ( 1.1 ). The treatment of ocular itching associated with allergic conjunctivitis in adults and pediatric patients aged 2 years and older. The use of DEXTENZA is not recommended for the treatment of ocular itching associated with allergic conjunctivitis in pediatric patients who require sedation for the insertion procedure. ( 1.2 ). 1.1 Ocular Inflammation and Pain Following Ophthalmic Surgery DEXTENZA is indicated for the treatment of ocular inflammation and pain following ophthalmic surgery ( 1.1 ). 1.2 Itching Associated with Allergic Co…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70382-204

What is NDC 70382-204?: 70382-204 is the product NDC for Dextenza (dexamethasone), Dexamethasone .4 mg/1 insert, listed with the FDA by Ocular Therapeutix, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dextenza (Dexamethasone).
What is the active ingredient?: Dexamethasone.
Who is the labeler?: Ocular Therapeutix, Inc., NDC labeler code 70382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dextenza?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Dextenza (Dexamethasone) NDC 70382-204